Works by de Bruijn, Peter

Results: 34

Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.

Published in:

PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198289

By:

Kuip, Evelien J. M.;
Oldenmenger, Wendy H.;
Thijs—Visser, Martine F.;
de Bruijn, Peter;
Oosten, Astrid W.;
Oomen—de Hoop, Esther;
Koolen, Stijn L. W.;
Van der Rijt, Carin C. D.;
Mathijssen, Ron H. J.

Publication type:

Article

Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice.

Published in:

2016

By:

Huisman, Sander A;
Bruijn, Peter;
Ghobadi Moghaddam ‐ Helmantel, Inge M;
IJzermans, Jan N M;
Wiemer, Erik A C;
Mathijssen, Ron H J;
Bruin, Ron W F;
de Bruijn, Peter;
Ghobadi Moghaddam-Helmantel, Inge M;
de Bruin, Ron W F

Publication type:

journal article

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 841, doi. 10.1007/s00280-007-0671-9

By:

Heijns, Joan B.;
van der Burg, Maria E. L.;
van Gelder, Teun;
Fieren, Marien W. J. A.;
de Bruijn, Peter;
van der Gaast, Ate;
Loos, Walter J.

Publication type:

Article

Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 3, p. 407, doi. 10.1007/s00280-006-0359-6

By:

Loos, Walter J.;
de Wit, Ronald;
Freedman, Steven J.;
Van Dyck, Kristien;
Gambale, Jay J.;
Li, Susie;
Murphy, Gail M.;
van Noort, Connie;
de Bruijn, Peter;
Verweij, Jaap

Publication type:

Article

Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.

Published in:

2004

By:

Mathijssen, Ron H. J.;
de Jong, Floris A.;
van Schaik, Ron H. N.;
Lepper, Erin R.;
Friberg, Lena E.;
Rietveld, Trinet;
de Bruijn, Peter;
Graveland, Wilfried J.;
Figg, William D.;
Verweij, Jaap;
Sparreboom, Alex

Publication type:

journal article

Effects of St. John's Wort on Irinotecan Metabolism.

Published in:

JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 16, p. 1247, doi. 10.1093/jnci/94.16.1247

By:

Mathijssen, Ron H.J.;
Verweij, Jaap;
De Bruijn, Peter;
Loos, Walter J.;
Sparreboom, Alex

Publication type:

Article

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221081075

By:

Buck, Stefan A. J.;
Braal, C. Louwrens;
Hofman, Maaike M.;
Oomen-de Hoop, Esther;
Bruijn, Peter de;
Ghobadi Moghaddam-Helmantel, Inge M.;
Hussaarts, Koen G. A. M.;
Vastbinder, Mijntje B.;
van Rossum-Schornagel, Quirine C.;
van Schaik, Ron H. N.;
Jager, Agnes;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.

Publication type:

Article

Biliary Excretion of Imatinib and Its Active Metabolite CGP74588 During Severe Hepatic Dysfunction.

Published in:

2012

By:

Schiavon, Gaia;
Eechoute, Karel;
Mathijssen, Ron H. J.;
de Bruijn, Peter;
van der Bol, Jessica M.;
Verweij, Jaap;
Sleijfer, Stefan;
Loos, Walter J.

Publication type:

Case Study

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

Published in:

Cancers, 2023, v. 15, n. 3, p. 915, doi. 10.3390/cancers15030915

By:

Feijtel, Danny;
Reuvers, Thom G. A.;
van Tuyll-van Serooskerken, Christine;
de Ridder, Corrina M. A.;
Stuurman, Debra C.;
de Blois, Erik;
Verkaik, Nicole S.;
de Bruijn, Peter;
Koolen, Stijn L. W.;
de Jong, Marion;
Nonnekens, Julie

Publication type:

Article

Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel.

Published in:

Cancers, 2021, v. 13, n. 15, p. 3915, doi. 10.3390/cancers13153915

By:

van Doorn, Leni;
van Rosmalen, Mandy M.;
van der Deure, Wendy M.;
Oomen-de Hoop, Esther;
Porrazzo, Robert;
Wijngaard, Sophie M.;
Boere, Ingrid A.;
Veenstra, Paola;
Ibrahim, Eman;
de Bruijn, Peter;
Friberg, Lena E.;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
Jager, Agnes

Publication type:

Article

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634.

Published in:

Cancers, 2021, v. 13, n. 15, p. 3741, doi. 10.3390/cancers13153741

By:

Atrafi, Florence;
van Eerden, Ruben A. G.;
Koolen, Stijn L. W.;
de Bruijn, Peter;
Rijcken, Cristianne J. F.;
Hanssen, Rob;
Eskens, Ferry A. L. M.;
Lolkema, Martijn P.;
Oomen-de Hoop, Esther;
Damman, Jeffrey;
Mathijssen, Ron H. J.

Publication type:

Article

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.

Published in:

Cancers, 2018, v. 10, n. 11, p. 445, doi. 10.3390/cancers10110445

By:

Kuip, Evelien J. M.;
Oldenmenger, Wendy H.;
Oomen-de Hoop, Esther;
Verduijn, Gerda M.;
Thijs-Visser, Martine F.;
de Bruijn, Peter;
van Meerten, Esther;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
van der Rijt, Carin C. D.

Publication type:

Article

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

Published in:

2018

By:

Leblanc, Alix F;
Sprowl, Jason A;
Alberti, Paola;
Chiorazzi, Alessia;
Arnold, W David;
Gibson, Alice A;
Hong, Kristen W;
Pioso, Marissa S;
Chen, Mingqing;
Huang, Kevin M;
Chodisetty, Vamsi;
Costa, Olivia;
Florea, Tatiana;
de Bruijn, Peter;
Mathijssen, Ron H;
Reinbolt, Raquel E;
Lustberg, Maryam B;
Sucheston-Campbell, Lara E;
Cavaletti, Guido;
Sparreboom, Alex

Publication type:

journal article

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.759146

By:

van Eerden, Ruben A. G.;
van Doorn, Leni;
de Man, Femke M.;
Heersche, Niels;
Doukas, Michail;
van den Bosch, Thierry P. P.;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Bins, Sander;
Ibrahim, Eman;
Nikkessen, Suzan;
Friberg, Lena E.;
Koolen, Stijn L. W.;
Spaander, Manon C. W.;
Mathijssen, Ron H. J.

Publication type:

Article

Darolutamide does not interfere with OATP‐mediated uptake of docetaxel.

Published in:

International Journal of Cancer, 2024, v. 155, n. 2, p. 314, doi. 10.1002/ijc.34922

By:

Buck, Stefan A. J.;
Talebi, Zahra;
Drabison, Thomas;
Jin, Yan;
Gibson, Alice A.;
Hu, Peng;
de Bruijn, Peter;
de Ridder, Corrina M. A.;
Stuurman, Debra;
Hu, Shuiying;
van Weerden, Wytske M.;
Koolen, Stijn L. W.;
de Wit, Ronald;
Sparreboom, Alex;
Mathijssen, Ron H. J.;
Eisenmann, Eric D.

Publication type:

Article

Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel.

Published in:

Oncologist, 2007, v. 12, n. 3, p. 291, doi. 10.1634/theoncologist.12-3-291

By:

Engels, Frederike K.;
De Jong, Floris A.;
Sparreboom, Alex;
Mathot, Ron A. A.;
Loos, Walter J.;
Kitzen, Jos J. E. M.;
De Bruijn, Peter;
Verweij, Jaap;
Mathijssen, Ron H. J.

Publication type:

Article

Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.

Published in:

Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944

By:

DE JONG, FLORIS A.;
KEHRER, DIEDERIK F. S.;
MATHIJSSEN, RON H. J.;
CREEMERS, GEERT-JAN;
DE BRUIJN, PETER;
VAN SCHAIK, RON H. N.;
PLANTING, ANDRÉ S. TH.;
VAN DER GAAST, ATE;
ESKENS, FERRY A. L. M.;
JANSSEN, JOS TH. P.;
RUIT, JAN B.;
VERWEIJ, JAAP;
SPARREBOOM, ALEX;
DE JONGE, MAJA J. A.

Publication type:

Article

A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 12, p. 1687, doi. 10.3390/ph17121687

By:

Ntafoulis, Ioannis;
Koolen, Stijn L. W.;
van Tellingen, Olaf;
den Hollander, Chelsea W. J.;
Sabel-Goedknegt, Hendrika;
Dijkhuizen, Stephanie;
Haeck, Joost;
Reuvers, Thom G. A.;
de Bruijn, Peter;
van den Bosch, Thierry P. P.;
van Dis, Vera;
Gao, Zhenyu;
Dirven, Clemens M. F.;
Leenstra, Sieger;
Lamfers, Martine L. M.

Publication type:

Article

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 46, doi. 10.3390/ph14010046

By:

Hussaarts, Koen G. A. M.;
van Doorn, Leni;
Bins, Sander;
Sprengers, Dave;
de Bruijn, Peter;
van Leeuwen, Roelof W. F.;
Koolen, Stijn L. W.;
van Gelder, Teun;
Mathijssen, Ron H. J.

Publication type:

Article

Effectiveness and cost-effectiveness of early assisted discharge for Chronic Obstructive Pulmonary Disease exacerbations: the design of arandomised controlled trial.

Published in:

BMC Public Health, 2010, v. 10, n. 1, p. 618, doi. 10.1186/1471-2458-10-618

By:

Utens, Cecile M. A.;
Goossens, Lucas M. A.;
Smeenk, Frank W. J. M.;
van Schayck, Onno C. P.;
van Litsenburg, Walter;
Janssen, Annet;
van Vliet, Monique;
Seezink, Wiel;
Demunck, Dirk R. A. J.;
van de Pas, Brigitte;
de^Bruijn, Peter J.;
van der Pouw, Anouschka;
Retera, Jeroen M. A. M.;
de Laat-Bierings, Petra;
van Eijsden, Loes;
Braken, Maria;
Eijsermans, Riet;
Mölken, Maureen P. M. H. Rutten-van

Publication type:

Article

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.

Published in:

Prostate, 2016, v. 76, n. 10, p. 927, doi. 10.1002/pros.23182

By:

de Morrée, Ellen;
van Soest, Robert;
Aghai, Ashraf;
de Ridder, Corrina;
de Bruijn, Peter;
Ghobadi Moghaddam‐Helmantel, Inge;
Burger, Herman;
Mathijssen, Ron;
Wiemer, Erik;
de Wit, Ronald;
van Weerden, Wytske

Publication type:

Article

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.

Published in:

Pharmaceutics, 2020, v. 12, n. 9, p. 788, doi. 10.3390/pharmaceutics12090788

By:

Hussaarts, Koen G. A. M.;
van Doorn, Leni;
Eechoute, Karel;
Damman, Jeffrey;
Fu, Qiang;
van Doorn, Nadia;
Eisenmann, Eric D.;
Gibson, Alice A.;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Baker, Sharyn D.;
Koolen, Stijn L. W.;
van Gelder, Teun;
van Leeuwen, Roelof W. F.;
Mathijssen, Ron H. J.;
Sparreboom, Alex;
Bins, Sander

Publication type:

Article

Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 455, doi. 10.1002/cpt.2444

By:

van Doorn, Leni;
Heersche, Niels;
de Man, Femke M.;
de Bruijn, Peter;
Bijl, Ivo;
Oomen‐de Hoop, Esther;
Eskens, Ferry A. L. M.;
van der Gaast, Ate;
Mathijssen, Ron H. J.;
Bins, Sander

Publication type:

Article

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study.

Published in:

2022

By:

Tullemans, Bibian M. E.;
Brouns, Sanne L. N.;
Swieringa, Frauke;
Sabrkhany, Siamack;
van den Berkmortel, Franchette W. P. J.;
Peters, Natascha A. J. B.;
de Bruijn, Peter;
Koolen, Stijn L. W.;
Heemskerk, Johan W. M.;
Aarts, Maureen J. B.;
Kuijpers, Marijke J. E.

Publication type:

journal article

Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.

Published in:

2021

By:

Braal, C. Louwrens;
Hussaarts, Koen G. A. M.;
Seuren, Lieke;
Oomen‑deHoop, Esther;
de Bruijn, Peter;
Buck, ·Stefan A. J.;
Bos, Monique E. M. M.;
Thijs‑Visser, Martine F.;
Zuetenhorst, Hanneke J. M.;
Mathijssen‑van Stein, Daniëlle;
Vastbinder, Mijntje B.;
van Leeuwen, Roelof W. F.;
van Gelder, Teun;
Koolen, Stijn L. W.;
Jager, Agnes;
Mathijssen, Ron H. J.

Publication type:

Correction Notice

Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.

Published in:

Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 107, doi. 10.1007/s10549-020-05829-6

By:

Braal, C. Louwrens;
Hussaarts, Koen G. A. M.;
Seuren, Lieke;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Buck, Stefan A. J.;
Bos, Monique E. M. M.;
Thijs-Visser, Martine F.;
Zuetenhorst, Hanneke J. M.;
Mathijssen-van Stein, Daniëlle;
Vastbinder, Mijntje B.;
van Leeuwen, Roelof W. F.;
van Gelder, Teun;
Koolen, Stijn L. W.;
Jager, Agnes;
Mathijssen, Ron H. J.

Publication type:

Article

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles.

Published in:

Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 4, p. 309, doi. 10.1007/s002800000215

By:

van Zuylen, Lia;
Karlsson, Mats O.;
Verweij, Jaap;
Brouwer, Eric;
de Bruijn, Peter;
Nooter, Kees;
Stoter, Gerrit;
Sparreboom, Alex

Publication type:

Article

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1037, doi. 10.1007/s40262-024-01390-3

By:

Guchelaar, Niels A. D.;
Buck, Stefan A. J.;
van Doorn, Leni;
Hussaarts, Koen G. A. M.;
Sandberg, Yorick;
van der Padt-Pruijsten, Annemieke;
van Alphen, Robbert J.;
Poppe-Manenschijn, Laura;
Vleut, Isolde;
de Bruijn, Peter;
van Leeuwen, Roelof W. F.;
Mostert, Bianca;
Eskens, Ferry A. L. M.;
Oomen-de Hoop, Esther;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.

Publication type:

Article

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1129, doi. 10.1007/s40262-023-01260-4

By:

van Eerden, Ruben A. G.;
IJzerman, Nikki S.;
van Meekeren, Milan;
Oomen-de Hoop, Esther;
Guchelaar, Niels A. D.;
Visser, Andrea M. W.;
Matic, Maja;
van Schaik, Ron H. N.;
de Bruijn, Peter;
Moes, Dirk-Jan A. R.;
Jobse, Pieter A.;
Gelderblom, Hans;
Huitema, Alwin D. R.;
Steeghs, Neeltje;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.

Publication type:

Article

Influence of Darolutamide on Cabazitaxel Systemic Exposure.

Published in:

2022

By:

Buck, Stefan A. J.;
Guchelaar, Niels A. D.;
de Bruijn, Peter;
Ghobadi Moghaddam-Helmantel, Inge M.;
Oomen-de Hoop, Esther;
Westgeest, Hans M.;
Hamberg, Paul;
Mathijssen-van Stein, Danielle;
Lolkema, Martijn P.;
Koolen, Stijn L. W.;
de Wit, Ronald;
Mathijssen, Ron H. J.

Publication type:

Letter

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer.

Published in:

2022

By:

Braal, C. Louwrens;
Jager, Agnes;
Hoop, Esther Oomen-de;
Westenberg, Justin D.;
Lommen, Koen M. W. T.;
de Bruijn, Peter;
Vastbinder, Mijntje B.;
van Rossum-Schornagel, Quirine C.;
Thijs-Visser, Martine F.;
van Alphen, Robbert J.;
Struik, Liesbeth E. M.;
Zuetenhorst, Hanneke J. M.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.

Publication type:

journal article

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

Published in:

2017

By:

Oosten, Astrid;
Abrantes, João;
Jönsson, Siv;
Matic, Maja;
Schaik, Ron;
Bruijn, Peter;
Rijt, Carin;
Mathijssen, Ron;
Oosten, Astrid W;
Abrantes, João A;
Jönsson, Siv;
van Schaik, Ron H N;
de Bruijn, Peter;
van der Rijt, Carin C D;
Mathijssen, Ron H J

Publication type:

journal article

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.

Published in:

2017

By:

Bins, Sander;
Eechoute, Karel;
Kloth, Jacqueline;
Man, Femke;
Oosten, Astrid;
Bruijn, Peter;
Sleijfer, Stefan;
Mathijssen, Ron;
Kloth, Jacqueline S L;
de Man, Femke M;
Oosten, Astrid W;
de Bruijn, Peter;
Mathijssen, Ron H J

Publication type:

journal article

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch.

Published in:

2016

By:

Binkhorst, Lisette;
Bannink, Marjolein;
Bruijn, Peter;
Ruit, Jan;
Droogendijk, Helga;
Alphen, Robbert;
Boer, Tilly;
Lam, Mei;
Jager, Agnes;
Gelder, Teun;
Mathijssen, Ron;
de Bruijn, Peter;
van Alphen, Robbert J;
den Boer, Tilly D;
Lam, Mei Ho;
van Gelder, Teun;
Mathijssen, Ron H J

Publication type:

journal article